The study demonstrated a slight trend to increased predicted final adult height (+0.6 S.D.) in the testolactone/flutamide group, however, the difference was not statistically different.
← all excerpts
Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia.
1
—
—